In the current work, evidence was obtained demonstrating that OLR1 was expressed at a high level in colon cancer tissues, shared negative correlation with the survival of patients with colon cancer, and facilitated glycolytic metabolism to promote proliferation and chemoresistance of colon cancer cells. The gene discussed is OLR1; the disease is malignant colon neoplasm.